Development of a prognostically relevant cachexia index in primary myelofibrosis using serum albumin and cholesterol levels

• Ayalew Tefferi,
• Maura Nicolosi,
• Domenico Penna,
• Mythri Mudireddy,
• Natasha Szuber,
• Terra L. Lasho,
• Curtis A. Hanson,
• Rhett P. Ketterling,
• Naseema Gangat,
• Animesh D. Pardanani

Affiliations

Ayalew Tefferi

Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN; Ayalew Tefferi, Division of Hematology, Department of Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905;

Maura Nicolosi

Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN

Domenico Penna

Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN

Mythri Mudireddy

Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN

Natasha Szuber

Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN

Terra L. Lasho

Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN

Curtis A. Hanson

Division of Hematopathology, Department of Laboratory Medicine, Mayo Clinic, Rochester, MN

Rhett P. Ketterling

Division of Laboratory Genetics and Genomics, Department of Laboratory Medicine, Mayo Clinic, Rochester, MN

Naseema Gangat

Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN

Animesh D. Pardanani

Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN